SCHEMBL4034138

SCHEMBL4034138

O=C(O)Cc1nc(-c2ccccn2)no1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 15/20 0.65
RAB9A P51151 15/20 0.65
SMN1; SMN2 Q16637 14/20 0.65
ALDH1A1 P00352 5/20 0.65
TSHR P16473 4/20 0.62
KDM4E B2RXH2 2/20 0.62
AKR1B1 P15121 1/20 0.61
HTT P42858 2/20 0.59
NPSR1 Q6W5P4 2/20 0.58
TP53 P04637 4/20 0.55
PKM P14618 2/20 0.55
NFKB1 P19838 2/20 0.53
NFKB2 Q00653 2/20 0.53
RELA Q04206 2/20 0.53
GAA P10253 1/20 0.53
MAPT P10636 2/20 0.52
HSD17B10 Q99714 2/20 0.52
LMNA P02545 1/20 0.52
HPGD P15428 1/20 0.52
KLF5 Q13887 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6384896 0.99 NPC1 (0.63) NPC1RAB9ASMN1; SMN2ALDH1A1TSHR
SCHEMBL7538471 0.92 NPC1 (0.56) NPC1RAB9ASMN1; SMN2ALDH1A1TSHR
Lithium Ion SCHEMBL6384886 0.86 NPC1 (0.58) NPC1RAB9ASMN1; SMN2ALDH1A1TSHR
SCHEMBL3517537 0.86 NPC1 (0.68) NPC1RAB9ASMN1; SMN2ALDH1A1TSHR
SCHEMBL5717831 0.83 NPC1 (0.70) NPC1RAB9ASMN1; SMN2ALDH1A1TSHR
SCHEMBL8900290 0.81 NPC1 (0.68) NPC1RAB9ASMN1; SMN2ALDH1A1TSHR
SCHEMBL1812927 0.81 NPC1 (0.67) NPC1RAB9ASMN1; SMN2ALDH1A1TSHR
SCHEMBL5206454 0.79 NPC1 (0.63) NPC1RAB9ASMN1; SMN2ALDH1A1TSHR
SCHEMBL334041 0.78 NPC1 (0.68) NPC1RAB9ASMN1; SMN2ALDH1A1TSHR
SCHEMBL8889364 0.78 NPC1 (0.62) NPC1RAB9ASMN1; SMN2ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1212299-B1 SUBSTITUTED PIPERIDINE COMPOUNDS USEFUL AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY ASTRAZENECA UK LTD (GB) 2009-04-08 EP disclosed
US-6903085-B1 Substituted piperidine compounds useful as modulators of chemokine receptor activity ASTRAZENECA, AB (CH) 2005-06-07 US disclosed
EP-1212299-A1 SUBSTITUTED PIPERIDINE COMPOUNDS USEFUL AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY AstraZeneca UK Limited (GB) 2002-06-12 EP disclosed
WO-2001014333-A1 SUBSTITUTED PIPERIDINE COMPOUNDS USEFUL AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY ASTRAZENECA UK LIMITED (GB) 2001-03-01 WO disclosed